PLoS Pathogens (Aug 2019)

Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis.

  • Daniel T Claiborne,
  • Eileen P Scully,
  • Christine D Palmer,
  • Jessica L Prince,
  • Gladys N Macharia,
  • Jakub Kopycinski,
  • Clive M Michelo,
  • Howard W Wiener,
  • Rachel Parker,
  • Krystelle Nganou-Makamdop,
  • Daniel Douek,
  • Marcus Altfeld,
  • Jill Gilmour,
  • Matt A Price,
  • Jianming Tang,
  • William Kilembe,
  • Susan A Allen,
  • Eric Hunter

DOI
https://doi.org/10.1371/journal.ppat.1007981
Journal volume & issue
Vol. 15, no. 8
p. e1007981

Abstract

Read online

Despite extensive research on the mechanisms of HLA-mediated immune control of HIV-1 pathogenesis, it is clear that much remains to be discovered, as exemplified by protective HLA alleles like HLA-B*81 which are associated with profound protection from CD4+ T cell decline without robust control of early plasma viremia. Here, we report on additional HLA class I (B*1401, B*57, B*5801, as well as B*81), and HLA class II (DQB1*02 and DRB1*15) alleles that display discordant virological and immunological phenotypes in a Zambian early infection cohort. HLA class I alleles of this nature were also associated with enhanced immune responses to conserved epitopes in Gag. Furthermore, these HLA class I alleles were associated with reduced levels of lipopolysaccharide (LPS) in the plasma during acute infection. Elevated LPS levels measured early in infection predicted accelerated CD4+ T cell decline, as well as immune activation and exhaustion. Taken together, these data suggest novel mechanisms for HLA-mediated immune control of HIV-1 pathogenesis that do not necessarily involve significant control of early viremia and point to microbial translocation as a direct driver of HIV-1 pathogenesis rather than simply a consequence.